Carl Landgren, MD
Hematology & Oncology · Miami, FLNPI 1972926871
Payments from drug & device makers
Across 768 payments — averaging $62,299 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$35.3M
- Pfizer$7.4M
- Janssen Research & Development, LLC$2.3M
- Sanofi US Services Inc.$1M
- Bristol Myers Squibb$926K
- Menarini Silicon Biosystems, Inc.$427K
- plus $420K from 24 others
Across 9 payments — averaging $1607.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$10K
- Pfizer$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 94 | $35,312,402 |
| Pfizer | 235 | $7,418,710 |
| Janssen Research & Development, LLC | 151 | $2,336,169 |
| Sanofi US Services Inc. | 24 | $1,005,172 |
| Bristol Myers Squibb | 19 | $925,995 |
| Menarini Silicon Biosystems, Inc. | 36 | $427,175 |
| GSK | 29 | $113,523 |
| Adaptive Biotechnologies Corporation | 33 | $67,157 |
| Sanofi | 32 | $46,683 |
| AbbVie | 15 | $42,894 |
| Regeneron | 18 | $22,559 |
| Johnson & Johnson | 26 | $20,240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $19,576 |
| Merck | 8 | $14,666 |
| Karyopharm Therapeutics Inc. | 8 | $11,744 |
| E.r. Squibb & Sons, L.L.C. | 5 | $10,316 |
| Janssen Scientific Affairs, LLC | 7 | $8,937 |
| Beigene USA, Inc. | 1 | $7,875 |
| Sanofi-aventis U.S. LLC | 1 | $7,000 |
| Modernatx, Inc. | 2 | $5,647 |
| The Binding Site Inc. | 7 | $5,484 |
| Beigene, Ltd. | 1 | $3,500 |
| AstraZeneca | 1 | $3,300 |
| Janssen Global Services, LLC | 3 | $2,440 |
| Dr.reddy's Laboratories,inc. | 1 | $2,000 |
| Gilead | 1 | $1,340 |
| Aadi Bioscience, Inc. | 2 | $1,275 |
| Celularity Inc. | 1 | $1,000 |
| Genentech, Inc. | 1 | $825 |
| Tempus AI, Inc | 1 | $29 |
How this compares
$47,845,634 in reported general payments places this provider in the 95th percentile of 694 hematology & oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Miami
- Dickran KazandjianMiami$8.4M
- Justin WattsMiami$7.9M
- Jaime MerchanMiami$7.9M
- Frances ValdesMiami$5.7M
- Manmeet AhluwaliaMiami$4.8M
- Izidore LossosMiami$4.4M
- Gerald SoffMiami$4.3M
- James HoffmanMiami$3.3M
- Ana Sandoval LeonMiami$3.2M
- Julio ChavezTampa$16.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.